$25.57

+0.10 (+0.39%)

After Hours: $24.50 (-1.07, -4.18%)

Weekly Expected Move ±4.8%

$23 $24 $25 $26 $28

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 46 · $1.1B mcap · 31M float · 1.54% daily turnover · Short 72% of daily vol

Credit Risk of going bust: higher than 70% of companies Debt: 38.8% of company value Bonds: none of note held by US funds details ▾

Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.35 (down 95%), Amphastar Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $688.3M against a stock market value of $1.08B.
Distance to default 3.43 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $307.3M (short-term plus half of long-term), stock volatility 53.9%; Altman Z 2.15. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE

47.1 / 100

NoneWeakNarrowWide

Primary source: Cost Advantage · ROIC: 7.5% · 5Y Avg: 22.9%

Cost Advantage ★

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. AMPH shows a Weak competitive edge (47.1/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 7.5% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$23

Low

$23

Avg Target

$23

High

Based on 1 analyst since Aug 6, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 3Hold: 8Sell: 1Strong Sell: 0

Rating Summary

ConsensusHold

Avg Target$23.00

Analysts1

Consensus Change History

Date	Field	From	To
2026-04-25	consensus	Buy	Hold

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-08-18	Barclays	—	$20	$23	+3	+7.6%	$21.37
2026-06-03	Barclays	—	$30	$20	-10	+8.4%	$18.45
2026-05-14	Wells Fargo	Benjamin Burnett	Initiated	$19	—	+3.7%	$18.32
2026-05-11	Piper Sandler	—	$32	$21	-11	+10.5%	$19.00
2026-04-20	Jefferies	Dennis Ding	Initiated	$22	—	-4.0%	$22.92
2025-12-08	Barclays	—	Initiated	$30	—	+15.3%	$26.01
2025-03-21	Piper Sandler	David Amsellem	$66	$32	-34	+13.1%	$28.29
2024-08-08	Piper Sandler	David Amsellem	$71	$66	-5	+52.4%	$43.30
2024-05-23	Piper Sandler	David Amsellem	$35	$71	+36	+63.9%	$43.31
2022-03-11	Piper Sandler	David Amsellem	Initiated	$35	—	+2.0%	$34.30

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. AMPH receives an overall rating of A-. Strongest factors: DCF (5/5), ROA (4/5), P/B (4/5). Areas of concern: D/E (1/5).

Rating Change History

Date	From	To
2026-05-12	A	A-
2026-05-08	A-	A
2026-05-04	A	A-
2026-04-01	B+	A
2026-03-30	A-	B+
2026-03-05	A	A-
2026-02-27	C	A
2026-02-26	B+	C
2026-02-09	A-	B+
2026-02-06	B+	A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 55 Grade A

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. AMPH scores highest in Value (84/100) and lowest in Growth (22/100). An overall grade of A places AMPH among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

2.03

Grey Zone

Piotroski F-Score

6/9

✓ ✓ ✗ ✓ ✓ ✗ ✓ ✓ ✗

Beneish M-Score

-2.73

Unlikely Manipulator

Ohlson O-Score

-7.19

Bankruptcy prob: 0.1%

Low Risk

Credit Rating

BBB

Score: 57.7/100

Trend: Deteriorating

Earnings Quality

75/100

OCF/NI: 2.35x

Accruals: -6.3%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AMPH scores 2.03, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AMPH scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. AMPH's score of -2.73 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AMPH's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AMPH receives an estimated rating of BBB (score: 57.7/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). AMPH's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

14.65x

PEG

-0.39x

P/S

1.49x

P/B

1.45x

P/FCF

5.84x

P/OCF

4.83x

EV/EBITDA

6.75x

EV/Revenue

1.77x

EV/EBIT

10.07x

EV/FCF

8.44x

Earnings Yield

8.80%

FCF Yield

17.13%

Shareholder Yield

5.04%

Graham Number

$26.35

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 14.6x earnings, AMPH trades at a reasonable valuation. An earnings yield of 8.8% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $26.35 per share, suggesting a potential 3% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.770

NI / EBT

Interest Burden

0.796

EBT / EBIT

EBIT Margin

0.176

EBIT / Rev

Asset Turnover

0.435

Rev / Assets

Equity Multiplier

2.202

Assets / Equity

ROE

10.3%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AMPH's ROE of 10.3% is driven by Asset Turnover (0.435), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

$15.10

Price/Value

1.34x

Margin of Safety

-33.67%

Premium

33.67%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with AMPH's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. AMPH trades at a 34% premium to its adjusted intrinsic value of $15.10, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 14.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$25.57

Median 1Y

$23.75

5th Pctile

$11.66

95th Pctile

$48.44

Ann. Volatility

43.5%

Analyst Target

$23.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Jack Yongfeng Zhang Chief Executive Officer, President, Chief Scientific Officer	$950,911	$3,301,981	$8,309,350
Mary Ziping Luo Chief Operating Officer, Chief Scientist and Chairman	$775,120	$1,391,976	$4,031,078
William J. Peters Chief Financial Officer, Executive Vice President of Finance, Treasurer, President of International Medication Systems, Limited, and Director	$649,846	$1,043,982	$3,238,682
Rong Zhou Senior Executive Vice President of Production and President of Amphastar Nanjing Pharmaceuticals, Co., Ltd	$717,587	$701,500	$2,542,634
Jacob Liawatidewi Executive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S.	$499,909	$591,979	$2,037,856

CEO Pay Ratio

126:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $8,309,350

Avg Employee Cost (SGA/emp): $65,693

Employees: 1,976

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

1,976

-2.6% YoY

Revenue / Employee

$364,315

Rev: $719,887,000

Profit / Employee

$49,643

NI: $98,094,000

SGA / Employee

$65,693

Avg labor cost proxy

R&D / Employee

$43,443

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	8.6%	14.7%	18.4%	19.7%	16.5%	18.8%	18.1%	18.7%	24.6%	23.6%	25.3%	25.6%	23.8%	23.3%	19.9%	18.3%	14.8%	12.9%	10.4%	10.3%	10.30%
ROA	5.7%	9.5%	11.9%	13.1%	11.2%	12.9%	12.5%	9.7%	11.9%	12.2%	13.2%	11.6%	10.2%	10.3%	8.9%	8.7%	7.0%	6.1%	4.8%	4.7%	4.68%
ROIC	8.7%	12.7%	15.9%	18.2%	17.1%	18.8%	20.5%	10.9%	14.9%	15.9%	17.6%	17.0%	16.4%	14.9%	13.7%	12.8%	10.7%	9.6%	7.7%	7.5%	7.54%
ROCE	9.2%	15.0%	18.1%	19.1%	16.6%	18.2%	18.3%	12.0%	14.7%	15.4%	16.1%	17.3%	15.3%	15.1%	14.1%	13.0%	11.0%	10.1%	8.7%	8.7%	8.66%
Gross Margin	45.6%	46.5%	46.4%	51.3%	48.7%	52.7%	52.7%	49.9%	60.0%	54.0%	50.8%	52.2%	54.0%	46.5%	50.0%	49.6%	51.4%	46.8%	41.1%	50.8%	50.83%
Operating Margin	22.1%	20.1%	18.0%	20.1%	19.3%	28.0%	23.9%	25.3%	40.3%	30.3%	27.9%	30.3%	30.2%	24.2%	21.9%	24.2%	13.2%	19.4%	8.0%	21.6%	21.60%
Net Margin	26.3%	16.3%	20.1%	14.0%	13.2%	25.1%	18.6%	17.9%	27.3%	20.3%	25.1%	20.8%	21.4%	20.4%	14.8%	17.8%	9.0%	13.3%	3.8%	16.5%	16.50%
EBITDA Margin	39.8%	28.0%	30.1%	24.6%	25.4%	36.5%	29.5%	29.8%	50.4%	36.3%	36.1%	40.0%	36.4%	34.9%	30.7%	35.5%	21.9%	29.8%	19.3%	33.5%	33.53%
FCF Margin	10.8%	16.1%	22.0%	14.8%	18.5%	13.1%	9.9%	18.6%	23.3%	22.6%	23.8%	25.0%	23.6%	23.6%	20.6%	15.6%	15.7%	16.8%	18.8%	20.9%	20.94%
OCF Margin	18.0%	22.4%	27.7%	20.3%	23.6%	17.9%	15.2%	24.2%	29.1%	28.5%	29.3%	29.8%	28.9%	29.2%	26.5%	22.2%	21.1%	21.7%	23.4%	25.3%	25.29%
ROE 3Y Avg	snapshot only																				17.12%
ROE 5Y Avg	snapshot only																				17.37%
ROA 3Y Avg	snapshot only																				8.00%
ROIC 3Y Avg	snapshot only																				14.32%
ROIC Economic	snapshot only																				6.10%
Cash ROA	snapshot only																				10.59%
Cash ROIC	snapshot only																				15.83%
CROIC	snapshot only																				13.11%
NOPAT Margin	snapshot only																				12.05%
Pretax Margin	snapshot only																				13.98%
R&D / Revenue	snapshot only																				12.95%
SGA / Revenue	snapshot only																				19.08%
SBC / Revenue	snapshot only																				3.95%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	26.35	18.77	22.94	20.37	19.21	15.86	20.92	29.94	18.33	23.84	15.05	12.50	15.96	12.12	10.21	8.20	11.38	12.88	11.49	11.36	14.649
P/S Ratio	2.30	2.66	4.10	3.88	3.06	2.90	3.76	5.64	4.12	5.09	3.44	2.92	3.49	2.65	1.99	1.53	1.76	1.75	1.26	1.22	1.485
P/B Ratio	2.21	2.62	3.89	3.71	2.94	2.74	3.55	5.18	4.17	5.13	3.46	2.92	3.46	2.64	1.93	1.46	1.64	1.60	1.18	1.16	1.448
P/FCF	21.34	16.53	18.67	26.31	16.52	22.24	37.90	30.38	17.73	22.56	14.46	11.69	14.79	11.22	9.63	9.85	11.22	10.42	6.73	5.84	5.837
P/OCF	12.77	11.90	14.82	19.17	12.97	16.25	24.73	23.31	14.18	17.87	11.73	9.79	12.09	9.06	7.49	6.92	8.34	8.09	5.39	4.83	4.834
EV/EBITDA	12.05	10.14	13.13	12.20	10.69	9.41	12.25	20.74	12.68	15.17	10.22	8.55	10.79	8.79	7.18	6.16	7.45	7.77	6.80	6.75	6.750
EV/Revenue	2.28	2.59	3.92	3.71	2.89	2.76	3.58	6.31	4.74	5.66	3.94	3.49	4.02	3.24	2.56	2.12	2.28	2.27	1.81	1.77	1.768
EV/EBIT	18.41	13.34	16.34	14.94	13.54	11.67	15.15	25.22	15.05	18.36	12.54	10.57	13.66	11.16	9.27	8.15	10.24	10.97	10.13	10.07	10.072
EV/FCF	21.10	16.07	17.85	25.14	15.59	21.12	36.08	33.97	20.40	25.08	16.56	13.95	17.02	13.70	12.39	13.63	14.56	13.50	9.63	8.44	8.442
Earnings Yield	3.8%	5.3%	4.4%	4.9%	5.2%	6.3%	4.8%	3.3%	5.5%	4.2%	6.6%	8.0%	6.3%	8.3%	9.8%	12.2%	8.8%	7.8%	8.7%	8.8%	8.80%
FCF Yield	4.7%	6.1%	5.4%	3.8%	6.1%	4.5%	2.6%	3.3%	5.6%	4.4%	6.9%	8.6%	6.8%	8.9%	10.4%	10.2%	8.9%	9.6%	14.9%	17.1%	17.13%
Price/Tangible Book	snapshot only																				4.414
EV/OCF	snapshot only																				6.991
EV/Gross Profit	snapshot only																				3.708
Acquirers Multiple	snapshot only																				11.293
Shareholder Yield	snapshot only																				5.04%
Graham Number	snapshot only																				$26.35

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	3.10	3.06	3.19	3.64	3.76	3.99	3.86	1.53	2.10	2.17	2.18	3.52	3.43	3.07	2.95	3.29	3.12	4.02	3.85	2.40	2.397
Quick Ratio	2.08	2.17	2.35	2.69	2.75	2.90	2.88	1.11	1.68	1.70	1.72	2.63	2.61	2.19	2.02	2.21	2.21	2.90	2.82	1.71	1.714
Debt/Equity	0.25	0.23	0.22	0.21	0.20	0.19	0.19	0.90	1.13	0.98	0.93	0.87	0.87	0.89	0.87	0.87	0.85	0.83	0.89	0.90	0.896
Net Debt/Equity	-0.03	-0.07	-0.17	-0.16	-0.16	-0.14	-0.17	0.61	0.63	0.57	0.50	0.56	0.52	0.59	0.55	0.56	0.49	0.47	0.51	0.52	0.518
Debt/Assets	0.16	0.16	0.15	0.14	0.14	0.14	0.13	0.38	0.44	0.41	0.40	0.42	0.41	0.41	0.40	0.41	0.39	0.40	0.42	0.39	0.395
Debt/EBITDA	1.36	0.94	0.77	0.72	0.79	0.70	0.67	3.21	2.99	2.60	2.40	2.14	2.35	2.42	2.52	2.64	2.97	3.11	3.59	3.60	3.600
Net Debt/EBITDA	-0.14	-0.29	-0.60	-0.56	-0.64	-0.50	-0.62	2.19	1.66	1.53	1.29	1.39	1.41	1.60	1.60	1.71	1.71	1.77	2.05	2.08	2.082
Interest Coverage	63.40	96.07	96.12	81.85	69.60	63.86	64.83	26.57	10.40	7.31	6.01	5.82	6.35	6.97	7.17	7.30	6.37	5.85	4.99	4.91	4.905
Equity Multiplier	1.51	1.51	1.49	1.45	1.44	1.40	1.41	2.34	2.60	2.37	2.34	2.09	2.12	2.15	2.16	2.13	2.15	2.07	2.13	2.27	2.270
Cash Ratio	snapshot only																				1.102
Debt Service Coverage	snapshot only																				7.319
Cash to Debt	snapshot only																				0.421
FCF to Debt	snapshot only																				0.222
Defensive Interval	snapshot only																				679.0 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.65	0.67	0.67	0.69	0.70	0.71	0.70	0.51	0.53	0.57	0.58	0.50	0.47	0.47	0.46	0.46	0.45	0.45	0.44	0.43	0.435
Inventory Turnover	2.22	2.51	2.54	2.55	2.47	2.55	2.53	2.60	2.58	2.80	2.84	2.87	2.84	2.76	2.39	2.29	2.32	2.20	2.13	2.06	2.055
Receivables Turnover	6.33	6.05	6.02	6.41	6.25	5.95	5.97	5.83	6.13	6.33	5.66	6.04	5.58	5.81	5.15	5.45	5.05	5.14	4.93	5.25	5.255
Payables Turnover	10.37	10.22	10.44	8.51	12.06	11.71	10.99	10.61	10.60	12.77	10.65	12.88	10.31	12.82	8.04	9.77	9.82	11.53	8.59	10.79	10.787
DSO	58	60	61	57	58	61	61	63	60	58	64	60	65	63	71	67	72	71	74	69	69.5 days
DIO	164	145	144	143	148	143	144	140	141	130	128	127	129	132	153	159	158	166	171	178	177.6 days
DPO	35	36	35	43	30	31	33	34	34	29	34	28	35	28	45	37	37	32	42	34	33.8 days
Cash Conversion Cycle	187	170	169	157	176	173	172	168	166	159	159	159	159	166	178	189	193	205	203	213	213.2 days
Fixed Asset Turnover	snapshot only																				1.876
Operating Cycle	snapshot only																				247.0 days
Cash Velocity	snapshot only																				2.516
Capital Intensity	snapshot only																				2.389

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	22.4%	25.1%	23.6%	24.2%	17.5%	14.0%	14.0%	13.4%	24.0%	29.1%	30.4%	31.8%	19.9%	13.2%	7.7%	1.0%	0.3%	-1.3%	-1.1%	1.4%	1.35%
Net Income	4.4%	43.3%	31.6%	7.7%	1.1%	47.1%	14.6%	12.1%	75.2%	50.5%	66.0%	63.3%	16.6%	16.0%	-8.4%	-19.1%	-29.2%	-38.5%	-44.1%	-41.7%	-41.69%
EPS	4.4%	41.0%	30.1%	7.1%	1.0%	42.4%	14.6%	12.4%	71.5%	46.8%	62.8%	66.7%	21.2%	18.1%	-2.7%	-12.5%	-23.0%	-32.1%	-39.9%	-36.5%	-36.54%
FCF	2.4%	2.0%	1.2%	34.4%	1.0%	-7.6%	-48.6%	42.7%	55.7%	1.2%	2.1%	77.3%	21.7%	18.6%	-6.7%	-37.0%	-33.4%	-29.7%	-10.0%	36.3%	36.28%
EBITDA	1.1%	2.7%	3.5%	2.1%	67.8%	30.9%	11.4%	13.4%	71.8%	64.3%	72.3%	76.6%	19.3%	11.9%	-0.6%	-14.6%	-17.6%	-21.6%	-26.2%	-22.9%	-22.92%
Op. Income	5.2%	5.4%	4.9%	2.5%	93.6%	53.8%	46.9%	37.6%	92.6%	83.2%	77.3%	75.0%	18.5%	4.3%	-8.0%	-21.0%	-30.0%	-31.7%	-40.0%	-37.1%	-37.09%
OCF Growth	snapshot only																				15.63%
Asset Growth	snapshot only																				7.95%
Equity Growth	snapshot only																				1.41%
Debt Growth	snapshot only																				5.01%
Shares Change	snapshot only																				-8.11%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	15.9%	14.1%	12.9%	13.7%	13.8%	15.7%	16.6%	17.4%	21.3%	22.6%	22.5%	22.9%	20.4%	18.6%	17.0%	14.7%	14.3%	13.0%	11.6%	10.5%	10.51%
Revenue 5Y	9.0%	11.4%	12.5%	13.8%	14.8%	15.7%	16.5%	16.9%	17.8%	16.9%	16.4%	17.1%	17.0%	17.7%	17.3%	16.6%	16.5%	15.5%	14.4%	13.7%	13.71%
EPS 3Y	—	—	2.2%	17.2%	12.2%	19.1%	18.5%	1.8%	1.7%	3.4%	2.9%	1.5%	61.5%	35.2%	22.0%	17.9%	17.0%	5.6%	-1.6%	-2.6%	-2.56%
EPS 5Y	10.7%	40.3%	53.1%	82.7%	2.0%	80.8%	—	—	—	—	1.3%	24.7%	24.1%	24.0%	21.4%	1.0%	77.4%	1.3%	1.0%	53.1%	53.13%
Net Income 3Y	—	—	2.3%	19.8%	14.2%	23.1%	21.4%	1.9%	1.7%	3.6%	3.0%	1.5%	63.5%	36.9%	20.3%	14.0%	13.1%	2.4%	-5.3%	-8.3%	-8.32%
Net Income 5Y	11.6%	42.6%	55.5%	86.6%	2.0%	82.5%	—	—	—	—	1.3%	25.8%	24.9%	26.7%	22.2%	1.0%	75.8%	1.3%	99.7%	49.7%	49.68%
EBITDA 3Y	1.5%	1.4%	1.1%	92.5%	83.5%	87.7%	66.3%	75.0%	82.6%	99.7%	1.0%	83.2%	51.0%	34.0%	24.0%	19.6%	19.1%	12.9%	8.1%	5.1%	5.14%
EBITDA 5Y	9.8%	29.5%	39.9%	50.8%	63.4%	57.8%	83.5%	3.3%	1.2%	98.8%	80.2%	70.2%	66.2%	64.8%	51.1%	51.9%	43.0%	47.5%	44.4%	32.3%	32.26%
Gross Profit 3Y	24.7%	23.1%	20.3%	21.2%	20.6%	23.6%	24.6%	25.8%	32.6%	34.8%	34.0%	32.7%	28.3%	22.9%	20.6%	16.7%	15.1%	12.7%	8.5%	8.0%	8.01%
Gross Profit 5Y	9.0%	13.9%	15.6%	18.5%	21.0%	22.3%	25.7%	26.8%	28.5%	26.8%	24.7%	24.9%	23.4%	23.0%	21.8%	21.1%	20.6%	20.0%	17.6%	16.0%	16.01%
Op. Income 3Y	—	—	—	2.7%	2.8%	—	1.2%	1.7%	1.8%	1.6%	1.5%	1.0%	64.1%	43.2%	33.8%	23.9%	16.9%	9.3%	-0.7%	-4.5%	-4.54%
Op. Income 5Y	7.0%	34.8%	44.2%	81.3%	—	—	—	—	—	—	—	1.6%	1.6%	—	78.9%	93.4%	80.5%	66.6%	53.3%	33.2%	33.19%
FCF 3Y	—	—	—	38.1%	2.1%	5.8%	61.6%	—	1.2%	83.8%	52.8%	50.4%	56.3%	34.7%	14.5%	16.8%	8.0%	23.0%	38.0%	15.0%	15.03%
FCF 5Y	42.1%	32.6%	35.0%	33.4%	46.9%	73.8%	—	—	—	—	—	46.1%	1.3%	2.8%	65.3%	—	54.0%	38.9%	24.5%	23.9%	23.90%
OCF 3Y	24.6%	36.9%	68.7%	9.6%	35.9%	28.8%	18.9%	73.2%	56.0%	47.4%	36.2%	38.1%	40.9%	29.6%	15.3%	18.2%	10.0%	20.5%	28.9%	12.1%	12.14%
OCF 5Y	21.7%	20.5%	21.8%	18.0%	21.4%	17.9%	25.6%	39.1%	35.4%	36.9%	49.9%	23.7%	35.5%	38.6%	32.8%	44.6%	27.0%	22.2%	16.5%	18.0%	18.00%
Assets 3Y	10.7%	9.4%	9.6%	6.4%	7.5%	8.1%	10.5%	31.9%	36.0%	33.8%	34.6%	30.9%	33.3%	32.9%	31.4%	30.7%	31.9%	30.0%	28.7%	8.2%	8.16%
Assets 5Y	8.7%	9.4%	10.5%	10.3%	10.7%	10.3%	11.5%	25.0%	26.3%	24.1%	23.6%	19.9%	21.4%	21.9%	23.2%	21.9%	22.1%	20.9%	20.6%	21.2%	21.24%
Equity 3Y	10.4%	10.3%	12.7%	8.8%	9.1%	11.5%	13.3%	14.0%	13.7%	16.7%	18.4%	19.1%	19.2%	18.0%	16.1%	14.9%	15.4%	14.3%	12.1%	9.2%	9.24%
Book Value 3Y	9.1%	9.6%	11.6%	6.5%	7.2%	7.9%	10.5%	9.3%	10.7%	12.5%	15.7%	17.2%	17.7%	16.5%	17.7%	18.8%	19.4%	17.8%	16.4%	16.1%	16.11%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.80	0.88	0.91	0.92	0.95	0.96	0.97	0.97	0.95	0.91	0.89	0.89	0.94	0.96	0.97	0.95	0.96	0.94	0.92	0.89	0.890
Earnings Stability	0.13	0.33	0.44	0.38	0.57	0.64	0.69	0.58	0.71	0.79	0.78	0.67	0.76	0.82	0.75	0.85	0.75	0.61	0.38	0.29	0.291
Margin Stability	0.91	0.92	0.93	0.92	0.90	0.89	0.86	0.85	0.84	0.84	0.86	0.87	0.88	0.89	0.90	0.90	0.90	0.90	0.90	0.92	0.916
Rev. Growth Consistency	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	1.00	1.000
Earn. Growth Consistency	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.000
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.50	0.50	0.50	0.50	0.50	0.81	0.94	0.95	0.50	0.50	0.50	0.50	0.93	0.94	0.97	0.92	0.88	0.85	0.82	0.83	0.833
Earnings Smoothness	0.00	0.00	0.00	0.00	0.27	0.62	0.86	0.89	0.45	0.60	0.50	0.52	0.85	0.85	0.91	0.79	0.66	0.52	0.43	0.47	0.473
ROE Trend	0.01	0.07	0.10	0.16	0.10	0.10	0.08	0.07	0.11	0.06	0.06	0.06	0.03	0.02	-0.01	-0.03	-0.08	-0.09	-0.11	-0.10	-0.103
Gross Margin Trend	0.03	0.05	0.05	0.05	0.06	0.07	0.08	0.06	0.08	0.07	0.05	0.05	0.02	-0.01	-0.02	-0.03	-0.04	-0.03	-0.05	-0.04	-0.045
FCF Margin Trend	0.08	0.13	0.14	0.10	0.11	0.02	-0.07	0.04	0.09	0.08	0.08	0.08	0.03	0.06	0.04	-0.06	-0.08	-0.06	-0.03	0.01	0.007
Sustainable Growth Rate	8.6%	14.7%	18.4%	19.7%	16.5%	18.8%	18.1%	18.7%	24.6%	23.6%	25.3%	25.6%	23.8%	23.3%	19.9%	18.3%	14.8%	12.9%	10.4%	10.3%	10.30%
Internal Growth Rate	6.0%	10.5%	13.6%	15.1%	12.6%	14.9%	14.3%	10.7%	13.5%	13.9%	15.2%	13.1%	11.4%	11.5%	9.7%	9.5%	7.5%	6.5%	5.1%	4.9%	4.91%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	2.06	1.58	1.55	1.06	1.48	0.98	0.85	1.28	1.29	1.33	1.28	1.28	1.32	1.34	1.36	1.19	1.36	1.59	2.13	2.35	2.350
FCF/OCF	0.60	0.72	0.79	0.73	0.78	0.73	0.65	0.77	0.80	0.79	0.81	0.84	0.82	0.81	0.78	0.70	0.74	0.78	0.80	0.83	0.828
FCF/Net Income	snapshot only																				1.947
OCF/EBITDA	snapshot only																				0.965
CapEx/Revenue	7.2%	6.3%	5.7%	5.5%	5.1%	4.8%	5.3%	5.6%	5.8%	5.9%	5.5%	4.8%	5.3%	5.6%	5.9%	6.6%	5.4%	4.8%	4.7%	4.3%	4.34%
CapEx/Depreciation	snapshot only																				0.503
Accruals Ratio	-0.06	-0.06	-0.07	-0.01	-0.05	0.00	0.02	-0.03	-0.03	-0.04	-0.04	-0.03	-0.03	-0.03	-0.03	-0.02	-0.03	-0.04	-0.05	-0.06	-0.063
Sloan Accruals	snapshot only																				-0.059
Cash Flow Adequacy	snapshot only																				5.820
Earnings Quality Score	snapshot only																				0.750

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	52.2%	46.5%	32.4%	29.6%	45.7%	43.7%	50.1%	39.9%	56.3%	42.3%	43.6%	45.5%	38.5%	64.4%	68.1%	94.4%	37.6%	20.9%	49.2%	57.3%	57.29%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	2.0%	2.5%	1.4%	1.5%	2.4%	2.8%	2.4%	1.3%	3.1%	1.8%	2.9%	3.6%	2.4%	5.3%	6.7%	11.5%	3.3%	1.6%	4.3%	5.0%	5.04%
Net Buyback Yield	2.0%	2.5%	1.4%	1.5%	2.4%	2.8%	2.4%	1.3%	3.1%	1.7%	2.7%	3.2%	2.0%	5.0%	6.3%	11.5%	3.3%	1.5%	4.1%	4.9%	4.88%
Total Shareholder Return	2.0%	2.5%	1.4%	1.5%	2.4%	2.8%	2.4%	1.3%	3.1%	1.7%	2.7%	3.2%	2.0%	5.0%	6.3%	11.5%	3.3%	1.5%	4.1%	4.9%	4.88%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.72	0.74	0.76	0.78	0.77	0.80	0.78	0.79	0.80	0.81	0.84	0.83	0.85	0.84	0.82	0.83	0.82	0.79	0.77	0.77	0.770
Interest Burden (EBT/EBIT)	0.98	0.99	0.98	0.98	0.97	0.97	0.97	0.95	0.90	0.85	0.87	0.86	0.88	0.89	0.86	0.86	0.84	0.83	0.80	0.80	0.796
EBIT Margin	0.12	0.19	0.24	0.25	0.21	0.24	0.24	0.25	0.32	0.31	0.31	0.33	0.29	0.29	0.28	0.26	0.22	0.21	0.18	0.18	0.176
Asset Turnover	0.65	0.67	0.67	0.69	0.70	0.71	0.70	0.51	0.53	0.57	0.58	0.50	0.47	0.47	0.46	0.46	0.45	0.45	0.44	0.43	0.435
Equity Multiplier	1.51	1.54	1.54	1.51	1.47	1.45	1.45	1.93	2.06	1.93	1.92	2.20	2.34	2.25	2.25	2.11	2.13	2.11	2.15	2.20	2.202

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$0.72	$1.24	$1.56	$1.71	$1.46	$1.77	$1.79	$1.92	$2.51	$2.59	$2.92	$3.20	$3.04	$3.06	$2.84	$2.80	$2.34	$2.08	$1.71	$1.78	$1.78
Book Value/Share	$8.60	$8.90	$9.23	$9.38	$9.57	$10.22	$10.56	$11.10	$11.04	$12.06	$12.68	$13.71	$14.03	$14.07	$15.06	$15.74	$16.29	$16.72	$16.65	$17.37	$17.60
Tangible Book/Share	$7.82	$8.12	$8.49	$8.67	$8.87	$9.50	$9.84	$-0.68	$-0.45	$0.49	$1.23	$2.16	$2.56	$2.72	$3.34	$3.72	$4.29	$4.72	$4.60	$4.57	$4.57
Revenue/Share	$8.25	$8.75	$8.76	$8.96	$9.18	$9.65	$9.98	$10.19	$11.15	$12.16	$12.76	$13.70	$13.91	$14.01	$14.60	$14.97	$15.17	$15.26	$15.51	$16.51	$16.73
FCF/Share	$0.89	$1.41	$1.92	$1.32	$1.70	$1.26	$0.99	$1.89	$2.59	$2.74	$3.04	$3.42	$3.28	$3.31	$3.01	$2.33	$2.38	$2.57	$2.91	$3.46	$3.50
OCF/Share	$1.49	$1.96	$2.42	$1.81	$2.17	$1.72	$1.52	$2.47	$3.24	$3.46	$3.74	$4.08	$4.02	$4.10	$3.87	$3.32	$3.19	$3.31	$3.64	$4.17	$4.23
Cash/Share	$2.34	$2.73	$3.60	$3.49	$3.53	$3.40	$3.76	$3.16	$5.56	$4.84	$5.46	$4.18	$4.83	$4.26	$4.75	$4.82	$5.84	$6.00	$6.34	$6.56	$6.65
EBITDA/Share	$1.56	$2.23	$2.61	$2.73	$2.48	$2.83	$2.91	$3.10	$4.17	$4.53	$4.92	$5.58	$5.17	$5.16	$5.20	$5.15	$4.64	$4.47	$4.12	$4.32	$4.32
Debt/Share	$2.12	$2.09	$2.03	$1.95	$1.96	$1.98	$1.96	$9.96	$12.47	$11.76	$11.83	$11.92	$12.14	$12.50	$13.08	$13.62	$13.78	$13.91	$14.77	$15.56	$15.56
Net Debt/Share	$-0.22	$-0.64	$-1.57	$-1.54	$-1.58	$-1.42	$-1.80	$6.79	$6.91	$6.92	$6.37	$7.74	$7.31	$8.24	$8.33	$8.80	$7.93	$7.91	$8.44	$9.00	$9.00

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2.028
Altman Z-Prime	snapshot only																				4.153
Piotroski F-Score	7	7	7	7	8	7	8	4	5	4	4	8	8	7	6	5	5	7	5	6	6
Beneish M-Score	-2.30	-2.54	-2.76	-2.31	-2.74	-2.34	-2.08	-0.78	-0.83	-1.19	-1.06	-2.41	-2.42	-2.39	-2.61	-2.54	-2.75	-2.68	-2.65	-2.73	-2.732
Ohlson O-Score	snapshot only																				-7.193
ROIC (Greenblatt)	snapshot only																				16.93%
Net-Net WC	snapshot only																				$-7.79
EVA	snapshot only																				$-28648147.22

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				BBB
Credit Score	95.44	95.51	95.53	95.80	95.71	96.32	95.54	76.22	74.73	79.30	74.13	75.92	78.25	75.66	72.79	66.83	63.91	67.16	58.07	57.71	57.710
Credit Grade	snapshot only																				9
Credit Trend	snapshot only																				-9.116
Implied Spread (bps)	snapshot only																				275.000
Industry Credit Rank	snapshot only																				46
Sector Credit Rank	snapshot only																				51

AMPH NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet